RBBS
RBBS由 sufang 在 三, 04/01/2015 – 09:00 發表 Pre-published RBBS 須細讀, 台大擬用此法screen HNSCC patients. Start: 04/01/2015
RBBS由 sufang 在 三, 04/01/2015 – 09:00 發表 Pre-published RBBS 須細讀, 台大擬用此法screen HNSCC patients. Start: 04/01/2015
OSCC Cell Line STR information 20150312 更新版由 sufang 在 一, 03/30/2015 – 08:45 發表 Oral Cancer OSCC Cell Line STR analysis Dear all, 更新oral cancer相關細胞株之STR資訊共有16個細胞株, 其中DOK, FaDu, HOK, HSC-3, KB, OEC-M1, SCC-15, SCC-9, Tu-183(共9株)有送件STR的資訊(詳如附件)須請大家注意的資訊如下:1. HSC-3, 於Dr.郭靜娟’s lab的新HSC-3為真, 請非此來源者把舊的細胞扔了吧! (p.s Dr. 李岳倫於2014年7月及9月分別定的STR結果同新HSC-3, 推測亦為可用細胞株)2. KB, 於Dr.郭靜娟’s lab定STR結果為HeLa細胞, ATCC/JCRB資料庫也證明KB為HeLa. 請勿使用此細胞株!3. SCC-15, Dr.李岳倫’s lab 於2014年9月及10月分別定的STR結果皆與SAS細胞株相符(90.9% match), 使用此細胞株請小心!4. Tu-183, 於Dr.江士昇’s
OSCC Cell Line STR information 20150312 更新版 Read More »
2015/03/24 陳貞佩 Monensin inhibits epidermal growth factor receptor trafficking and activation: synergistic cytotoxicity in combination with EGFR inhibitors 2015/03/10 楊韻涵 NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival 2015/02/10 王思涵 Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration 2015/01/06 小嬿 RFTS-deleted DNMT1
由 sufang 在 五, 03/13/2015 – 08:29 發表 Pre-published 國長會議 長庚 國衛院長庚雙邊會議 2015/01/30 (五) at 林口長庚 王陸海: miR491-3p is responsible for oral cancer metastasis葉大森: bile duct cancer (miRNA 200下降), liver cancer (miRNA 200 上升,which is correlated with EMT)陳鈴津教授介紹 閻紫宸教授另外一個專長是 radio pharmatheutical research (新藥開發 GMP等等)———————–趙盈凱 副教授【胸腔外科】可吸收性生物醫材在食道癌之應用東方人食道癌 是由ABC引起的、西方的食道癌則多由胃食道逆流證實CCRT+Surgert is better therapy than just surgery-Big Database (2400 病人
3/6/2015 DR 提醒 1: Daw-Yang seems to use Clontech ds-cDNA prep for single cell Seq + Tagmentation 2: There is no way to add specific primer in this way… According to Daw-Yang: I will use Nexera XT for DNA prep. Figure 1 AMP for targeted RNA and DNA sequencing (pdf 4231). Double-stranded cDNA (dscDNA) synthesis
ds-cDNA prep for gene fusion detection Read More »
由 sufang 在 五, 02/27/2015 – 10:08 發表 Oral Cancer HNSCC TCGA Comprehensive genomic characterization of head and neck squamous cell carcinomas (pdf 4292; PubMed Link) The Cancer Genome Atlas profiled 279 head and neck squamous cell carcinomas (HNSCCs) to provide a comprehensive landscape of somatic genomic alterations. Here we show that human-papillomavirus-associated tumours are dominated by helical
TCGA HNSCC Marker Paper Read More »
寄送SW780 RNA給長庚及行動基因陳華鍵由 sufang 在 五, 02/13/2015 – 15:20 發表 Cholangiocarcinoma GeneFusion From: SuFang Lin [mailto:sflin1@gmail.com] Sent: Friday, January 30, 2015 2:06 PMTo: angel945@cgmh.org.twSubject: this is SuFang’s email Dear Dr. 趙:This is my email. I will prepare ~510 micrograms RNAs from SW780 cells for your control. Please let me know to whom and to where should I sent. Thanks! Best, SuFang ————————————– Angel
寄送SW780 RNA給長庚及行動基因陳華鍵 Read More »
Fusion gene detection 2014-Dec 及 TLCN檢體申請由 sufang 在 三, 01/21/2015 – 11:29 發表 Cholangiocarcinoma cholangiocarcinoma FGFR2 gene fusion Nov 27, 2014 at 2:57 PM To: Su-Fang Lin Dear SF, Only minor suggestions (in red color). Are you going to list the oncogenes screening in your proposal or we can just perform the exam? I am
Fusion gene detection 2014-Dec 及 TLCN檢體申請 Read More »
General Fluidigm Access Array + MySeq –YouTube 1: https://www.youtube.com/watch?v=s9HUhuCbbhU –YouTube 2: https://www.youtube.com/watch?v=WXpNjcRwdj8 –AA_Illumina_ug_100-3770 (pdf) –RecoverAll Total Nucleic Acid Isolation Kit for FFPE (pdf) 台大郭頌鑫醫師抽取DNA and RNA from tiny endoscopic biopsy samples使用。 –陳華鍵老師他們新開的公司行動基因,用的是類似方法、只是不同機器(Ion Torrent PGM/Proton) –Archer: Archer™ FusionPlex™ FGFR Panel (USD 495 / 8 rxn) –Life: Ion AmpliSeq™ RNA Fusion Lung Cancer Research Panel –與台大合作部分,詳見HPV and p16 in HNSCC. (按我連結) –ds-cDNA protocal from Yi-Mi and Dan (03/05/2015). (按我下載)
Collaborative Projects between KMUH and NICR Read More »
20150111_癌症個人化醫療前瞻論壇 @ 台北喜來登 星月廳 (B2F)由 sufang 在 日, 01/11/2015 – 20:41 發表 Pre-published Meeting Oral Cancer Opening remarks: 賴瓊慧教授 (副研發長) 主持人: 王子豪醫師 (國外廠商contact him about STIP1) 閻紫宸教授: 台灣口腔癌病患新穎癒後生物標誌的發現與臨床意義 –Why OSCC: Taiwan has the oral cancer incidence in men worldwide –Oral cavity cancer: incidence, survival and treatment –廖俊達教授is the head of CGH HNSCC group leader (pastic
癌症個人化醫療前瞻論壇 @ 台北喜來登 星月廳 (B2F) Read More »